143 related articles for article (PubMed ID: 35265100)
1. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma.
Chen L; Xu L; Shen L; Luo R; Jiang D; Wang Y; Li W; Hou Y
Front Genet; 2021; 12():831318. PubMed ID: 35265100
[TBL] [Abstract][Full Text] [Related]
2. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B
Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585
[TBL] [Abstract][Full Text] [Related]
3. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee SJ; Jeon DY
Eur J Surg Oncol; 2023 Feb; 49(2):392-398. PubMed ID: 36369228
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
[TBL] [Abstract][Full Text] [Related]
5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
6. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
Yoshida H; Shimada K; Kosuge T; Hiraoka N
Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
Yao JG; Wang CH; Liu Y
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
[No Abstract] [Full Text] [Related]
8. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer.
Hiraoka N; Nitta H; Ohba A; Yoshida H; Morizane C; Okusaka T; Nara S; Esaki M; Kishi Y; Shimada K
Hum Pathol; 2020 Nov; 105():9-19. PubMed ID: 32891647
[TBL] [Abstract][Full Text] [Related]
9. Significance of HER2 protein expression and
Wang XY; Zheng ZX; Sun Y; Bai YH; Shi YF; Zhou LX; Yao YF; Wu AW; Cao DF
World J Gastrointest Oncol; 2019 Apr; 11(4):335-347. PubMed ID: 31040898
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study.
Ramalhosa F; Amaral MJ; Serôdio M; Oliveira RC; Teixeira P; Cipriano MA; Tralhão JG
J Gastrointest Oncol; 2022 Aug; 13(4):1997-2006. PubMed ID: 36092357
[TBL] [Abstract][Full Text] [Related]
11. HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Vivaldi C; Fornaro L; Ugolini C; Niccoli C; Musettini G; Pecora I; Cacciato Insilla A; Salani F; Pasquini G; Catanese S; Lencioni M; Masi G; Campani D; Fontantini G; Falcone A; Vasile E
Oncologist; 2020 Oct; 25(10):886-893. PubMed ID: 32353192
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
Samuel S; Mukherjee S; Ammannagari N; Pokuri VK; Kuvshinoff B; Groman A; LeVea CM; Iyer R
PLoS One; 2018; 13(6):e0198809. PubMed ID: 29889907
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma involving the gallbladder: a retrospective review of 23 cases - pitfalls in diagnosis of gallbladder carcinoma.
Giang TH; Ngoc TT; Hassell LA
Diagn Pathol; 2012 Jan; 7():10. PubMed ID: 22284391
[TBL] [Abstract][Full Text] [Related]
14. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
15. Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas.
Augustin J; Gabignon C; Scriva A; Menu L; Calmel C; Scatton O; Paye F; Fléjou JF; Praz F; Cervera P; Wendum D
Virchows Arch; 2020 Jul; 477(1):33-45. PubMed ID: 32447492
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.
Schindlbeck C; Mayr D; Olivier C; Rack B; Engelstaedter V; Jueckstock J; Jenderek C; Andergassen U; Jeschke U; Friese K
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1029-37. PubMed ID: 20052594
[TBL] [Abstract][Full Text] [Related]
18. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).
Boers JE; Meeuwissen H; Methorst N
Histopathology; 2011 Feb; 58(3):383-94. PubMed ID: 21323962
[TBL] [Abstract][Full Text] [Related]
19. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
Erickson BK; Najjar O; Damast S; Blakaj A; Tymon-Rosario J; Shahi M; Santin A; Klein M; Dolan M; Cimino-Mathews A; Buza N; Ferriss JS; Stone RL; Khalifa M; Fader AN
Gynecol Oncol; 2020 Oct; 159(1):17-22. PubMed ID: 32709539
[TBL] [Abstract][Full Text] [Related]
20. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
Shi H; Shao Y; Lu W; Lu B
J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
